LONDON (Reuters) - AstraZeneca, determined to show it has a strong independent future after seeing off a $118 billion bid from Pfizer in May, said it had made good progress in developing a pipeline of new drugs.
via Reuters: Health News Read More Here..
No comments:
Post a Comment